What is SpineCare Delaware?
SpineCare Delaware operates as a premier ambulatory surgery center, carving out a distinct market position through its focus on minimally invasive spinal injections. By performing over 5,000 X-ray guided procedures annually, the facility demonstrates significant operational scale and clinical efficiency. The center is fully Medicare and AAAHC approved, reflecting a rigorous adherence to safety standards and patient care protocols. By leveraging state-of-the-art medical technology, SpineCare Delaware effectively bridges the gap between complex spinal interventions and outpatient convenience, catering to a growing demographic seeking efficient, high-quality orthopedic and neurological care solutions.
How much funding has SpineCare Delaware raised?
SpineCare Delaware has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in SpineCare Delaware
PPP
Public-Private Partnership
What's next for SpineCare Delaware?
The infusion of capital from this late-stage funding round positions SpineCare Delaware to further optimize its clinical infrastructure and expand its service delivery capabilities. As the healthcare landscape shifts toward value-based care and outpatient surgical settings, the company is well-positioned to capture additional market share. Strategic priorities likely include the integration of advanced diagnostic imaging, potential expansion of its physician network, and the enhancement of patient throughput systems to maintain its competitive edge. By focusing on operational scalability and maintaining its reputation for safety, SpineCare Delaware is prepared to navigate the complexities of the modern medical economy while continuing to deliver specialized spinal care at scale.
See full SpineCare Delaware company page
